Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- Annual Reports
Date | Form | Description | Docs | XBRL | Pages |
03/15/21 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() ![]() |
![]() ![]() ![]() |
166 |
03/24/20 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() ![]() |
![]() ![]() ![]() |
173 |
03/18/19 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
![]() ![]() |
![]() ![]() ![]() |
8 |
03/18/19 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() ![]() |
154 | |
03/09/18 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() ![]() |
![]() ![]() ![]() |
130 |
09/01/17 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
![]() ![]() |
24 | |
04/13/17 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() ![]() |
![]() ![]() ![]() |
88 |
03/31/17 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT |
![]() ![]() |
6 | |
04/28/16 | 10-K/A | Annual report pursuant to Section 13 and 15(d) |
![]() ![]() |
8 | |
03/03/16 | 10-K | Annual report pursuant to Section 13 and 15(d) |
![]() ![]() |
![]() ![]() ![]() |
97 |